stockrowBruker Corporation (BRKR) vs Insulet Corporation (PODD)
- Bruker Corporation BRKR 61.20 +5.41%
- Insulet Corporation PODD 146.38 −6.24%
Bruker Corporation and Insulet Corporation are both Medical Devices companies. Insulet Corporation is the larger, with a market value of $10.8B against $8.9B — 1.2× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Insulet Corporation trades at 23.8×. Insulet Corporation grew revenue faster over the last twelve months: 26.5% against 2.16%. Insulet Corporation has the higher net margin (13.5% vs −4.76%) and the higher return on invested capital (18.8% vs −1.12%). Across the 21 metrics below, Insulet Corporation leads on 16 and Bruker Corporation on 5.
Valuation
Profitability
| Metric | BRKR | PODD | Medical Devices median |
|---|---|---|---|
| Gross margin | 47.66% | 71.88% | 57.76% |
| Operating margin | (1.99%) | 18.43% | (14.84%) |
| Net margin | (4.76%) | 13.45% | (14.45%) |
| Free cash flow margin | 6.97% | 7.29% | (5.70%) |
| Return on equity | (7.04%) | 28.94% | (10.56%) |
| Return on assets | (2.73%) | 13.31% | (17.26%) |
| Return on invested capital | (1.12%) | 18.77% | (5.22%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack